Bispecific antibodies

These companies develop engineered antibodies that bind two targets at once or steer T cells to diseased cells.
+6.1%
over 1 month · S&P 500 −2.3%

Key indicators

Health
51 / 100
Fragile
Solid
Price
P/E 27
Cheap
Expensive
Up over 1 year
8 of 13
Wallets over 90 days
1 / 3 buys / sells
Buys
Sells
Health and price: against the other tags.